DVA - DaVita Non-GAAP EPS of $2.85 beats by $0.81 revenue of $3.12B beats by $100M
2023-11-07 16:11:20 ET
More on DaVita
- DaVita: Simple And Compelling After Sell-Off
- Should You Buy Baxter Or DaVita After The Fallout From The Ozempic Trial?
- DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
- DaVita Q3 2023 Earnings Preview
- Dialysis stocks decline again as Novo Nordisk hits 52-week high
For further details see:
DaVita Non-GAAP EPS of $2.85 beats by $0.81, revenue of $3.12B beats by $100M